WALTER V. KLEMP - 16 Jun 2021 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
CEO and President, Director
Signature
/s/ Walter V. Klemp
Issuer symbol
MBRX
Transactions as of
16 Jun 2021
Transactions value $
$0
Form type
4
Filing time
21 Jun 2021, 16:20:49 UTC
Next filing
06 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock option (right to buy) Award +224K +55.2% 629K 16 Jun 2021 Common Stock 224K $3.73 Direct F1, F2
transaction MBRX Restricted Stock Units Award +100K +15.9% 729K 16 Jun 2021 Common Stock 100K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest in four equal annual installments, beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
F2 Issued in connection with the reporting person's employment with the Company.
F3 Each restricted stock unit represents a contingent right to receive one share of Company common stock.
F4 The restricted stock units set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.